Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target
Creator
Xiao, Shaobo
Cai, Xuepeng
Cao, Wanlu
Chen, Sunrui
Dang, Wen
Pan, Qiuwei
Su, Junhong
Wang, Wenshi
Xu, Lei
Yin, Yuebang
Zhou, Xinying
Peppelenbosch, Maikel
Source
Medline; PMC
abstract
Rotavirus infection is a major cause of severe dehydrating diarrhea in infants younger than 5 y old and in particular cases of immunocompromised patients irrespective to the age of the patients. Although vaccines have been developed, antiviral therapy is an important complement that cannot be substituted. Because of the lack of specific approved treatment, it is urgent to facilitate the cascade of further understanding of the infection biology, identification of druggable targets and the final development of effective antiviral therapies. PI3K-Akt-mTOR signaling pathway plays a vital role in regulating the infection course of many viruses. In this study, we have dissected the effects of PI3K-Akt-mTOR signaling pathway on rotavirus infection using both conventional cell culture models and a 3D model of human primary intestinal organoids. We found that PI3K-Akt-mTOR signaling is essential in sustaining rotavirus infection. Thus, blocking the key elements of this pathway, including PI3K, mTOR and 4E-BP1, has resulted in potent anti-rotavirus activity. Importantly, a clinically used mTOR inhibitor, rapamycin, potently inhibited both experimental and patient-derived rotavirus strains. This effect involves 4E-BP1 mediated induction of autophagy, which in turn exerts anti-rotavirus effects. These results revealed new insights on rotavirus-host interactions and provided new avenues for antiviral drug development.
has issue date
2017-06-01
(
xsd:dateTime
)
bibo:doi
10.1080/21505594.2017.1326443
bibo:pmid
28475412
has license
cc-by
sha1sum (hex)
485b745f048cbac696175c1ca05eee8fb46ba026
schema:url
https://doi.org/10.1080/21505594.2017.1326443
resource representing a document's title
PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target
has PubMed Central identifier
PMC5955461
has PubMed identifier
28475412
schema:publication
Virulence
resource representing a document's body
covid:485b745f048cbac696175c1ca05eee8fb46ba026#body_text
is
schema:about
of
named entity 'ANTIVIRAL'
named entity 'cell culture'
named entity 'infection'
named entity 'strains'
named entity 'models'
named entity 'This'
named entity 'mediated'
named entity 'antiviral'
named entity 'ROTAVIRUS INFECTION'
named entity 'AUTOPHAGY PATHWAY'
named entity 'STRAINS'
named entity 'IMPORTANT'
named entity 'BIOLOGY'
named entity 'TARGET'
named entity 'MEDIATED'
named entity 'PI3K'
named entity 'TURN'
named entity 'INFANTS'
named entity 'LACK'
named entity 'INFECTION'
named entity 'SPECIFIC'
named entity 'CAUSE'
named entity 'URGENT'
named entity 'VACCINES'
named entity 'COMPLEMENT'
named entity 'STUDY'
named entity 'MODEL OF'
named entity 'IDENTIFICATION'
named entity 'EFFECTIVE'
named entity 'TREATMENT'
named entity 'INDUCTION'
named entity 'VIRUSES'
named entity 'USED'
named entity 'PROVIDED'
named entity 'ORGANOIDS'
named entity 'ESSENTIAL'
named entity 'COURSE'
named entity 'NEW'
named entity 'PATIENT'
named entity 'THESE'
named entity 'MEDIATED'
named entity 'REGULATING'
named entity 'THERAPIES'
named entity 'DISSECTED'
named entity 'AUTOPHAGY'
named entity '4E-BP1'
named entity 'AXIS'
named entity 'MTOR'
named entity 'AKT'
named entity 'AKT'
named entity 'EFFECT'
named entity 'YOUNGER'
named entity 'PRIMARY'
named entity 'FOUND'
named entity 'INSIGHTS'
named entity 'IS A'
named entity 'DERIVED'
named entity 'SUSTAINING'
named entity 'ROLE'
named entity 'HOST'
named entity 'ELEMENTS'
named entity 'AGE'
named entity 'DIARRHEA'
named entity 'EXPERIMENTAL'
named entity 'PATIENTS'
named entity 'UNDERSTANDING'
named entity 'HAVE'
named entity 'REVEALED'
named entity 'EXERTS'
named entity 'PI3K'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 11
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software